Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Hutchmed China Ltd ADR (HCM)

Hutchmed China Ltd ADR (HCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Hutchmed China Ltd ADR 48TH FLOOR CHEUNG KONG CENTER 2 QUEEN`S ROAD CENTRAL HONG KONG K3 HKG

www.hutch-med.com P: 852-2121-3888 F: 852-212-8177

Description:

HUTCHMED Limited is an innovative, commercial-stage, biopharmaceutical company. It is committed to the discovery and global development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. HUTCHMED Limited, formerly known as HUTCHMED (China) Limited, is based in HONG KONG.

Key Statistics

Overview:

Market Capitalization, $K 3,336,907
Enterprise Value, $K 3,132,667
Shares Outstanding, K 174,251
Annual Sales, $ 838,000 K
Annual Net Income, $ 100,780 K
Last Quarter Sales, $ 75,806 K
Last Quarter Net Income, $ -61,254 K
EBIT, $ 0 K
EBITDA, $ 26,590 K
60-Month Beta 0.77
% of Insider Shareholders 3.60%
% of Institutional Shareholders 8.82%
Float, K 167,978
% Float 96.40%
Short Volume Ratio 0.23

Growth:

1-Year Return 30.63%
3-Year Return -26.99%
5-Year Return -25.02%
5-Year Revenue Growth 291.39%
5-Year Earnings Growth 201.75%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 05/22/24
Earnings Per Share ttm 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

HCM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 12.03%
Debt/Equity 0.11
Price/Sales 4.07
Price/Cash Flow 31.27
Price/Book 4.58
Book Value/Share 4.27
Interest Coverage 77.72
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar